Bluestein Ventures

Bluestein Ventures Research Overview Bluestein Ventures is a Chicago-based, family-backed venture capital firm focused exclusively on the future of food. Founded in 2014 by Andrew Bluestein, the firm invests in early-stage ventures spanning the entire food industry value chain — from consumer brands to proprietary food technology, next-gen commerce, and digital infrastructure. The firm has closed three funds to date, with Fund III ($45M) closing in February 2024. As of mid-2025, Bluestein Ventures has backed 38+ companies across its fund lifecycle. Headquarters: 415 N LaSalle Drive, Suite 700A, Chicago, IL 60654 Investment Thesis "We invest in the future of food." Bluestein Ventures partners with visionaries transforming the food industry, seeking game-changing ventures that redefine how consumers achieve health and wellness. The firm looks for purpose-driven teams that pair strategic vision with flawless execution — founders challenging the status quo and translating ambition into tangible impact. The firm invests across four core categories spanning the food value chain: High-Growth Consumer Brands — Category-defining products for next-generation consumers emphasizing health, wellness, and performance optimization. Examples: Base Culture, Vive Organic, Mayu Water, Mezcla, Bizzy Coffee. Proprietary FoodTech — Technology-driven companies with defensible intellectual property creating transformational food products, including cell-based proteins, fermentation technology, bioactive ingredients, and novel food science. Examples: Meati, Mori, Jellatech, Lembas Bio, Cultured Decadence, BiomeSense, Aux Labs. Next-Gen Commerce — Omnichannel and digitally-forward food retail, delivery, and foodservice platforms leveraging emerging distribution models. Examples: Factor 75, Foxtrot, Crafty Delivers, Grovara, Local Foods, Attane Health. Value-Add Digital Technology — Software and data platforms improving efficiency, transparency, and access across the food supply chain. Examples: FourKites, Chowly, Provi, Hireology, Arise. Stage Focus and Check Size Bluestein Ventures invests from Pre-Seed through Series A, typically seeking to be among the first institutional investors in a company. With Fund III ($45M) planned for deployment across 20–25 companies, average check sizes are estimated at $1.5M–$2.5M. Earlier pre-seed checks likely run $250K–$750K, with Seed and Series A investments from $1M–$5M. The firm reserves capital for follow-on investments in portfolio winners. Recent Activity and Fund Status Fund III ($45M) closed in February 2024 with a continued focus on nutrition, sustainability, and digitization. The fund is actively deploying as of 2025–2026. Thematic priorities under Fund III include food-as-medicine — encompassing prescription food platforms, gut microbiome diagnostics, GLP-1 ingredient innovation, and immunity-focused nutrition. Recent portfolio investment activity: BiomeSense — gut microbiome research platform; $7M oversubscribed round closed October 2025 (Chicago Business Journal) ALTR (Altrfltr) — food-tech company; $5M seed round, July 2025 (Forbes-featured) Lembas Bio — GLP-1 ingredient manufacturer; $3.6M pre-seed, June 2025 (Forbes) Crafty Delivers — corporate amenities platform; $10M funding round with JLL & JLL Spark Global Ventures, November 2024 Mezcla — consumer nutrition brand; Series B, March 2026 Portfolio Highlights and Notable Exits Bluestein Ventures has backed 38+ companies since inception. Notable portfolio milestones: Factor 75 — meal delivery pioneer; acquired by HelloFresh, representing the firm's most prominent exit and validating its early-stage positioning in food delivery. FourKites — leading supply chain visibility platform; a breakout outcome in the digital technology category. Provi — beverage distribution platform; surpassed $5B in annual GMV flowing through its platform as of November 2025. Crafty Delivers — corporate snack and beverage delivery; secured $10M funding in 2024 and announced a major strategic partnership with Staples in June 2025. BiomeSense — raised an oversubscribed $7M round in 2025, demonstrating strong investor conviction in gut microbiome diagnostics. Meati — mycelium-based whole-cut meat alternative; a flagship FoodTech holding. Team Andrew Bluestein — Co-Founder & Managing Partner A former strategy consultant at Monitor Deloitte (7+ years), Andrew advised retail, CPG, hospitality, and business services companies before co-founding Bluestein Ventures in 2014. He serves on the boards of Factor_, Bizzy Coffee, and Local Foods, and holds observer roles on three additional portfolio boards. He mentors with Good Food Business Accelerator and 1871. Education: MBA with distinction from Kellogg School of Management; B.S. in Industrial and Labor Relations with Honors from Cornell University. LinkedIn: https://www.linkedin.com/in/andrewbluestein/ Ashley Hartman — Managing Partner Known as "The Operative" — Ashley brings an execution-first mindset honed from scaling family businesses and financial consulting work. She holds an MBA from Harvard Business School and focuses on health, wellness, and performance optimization within the portfolio. Recognized on Ingeborg's Healthcare Power Investor List (December 2025). LinkedIn: https://www.linkedin.com/in/ashleyhartman2/ Amira Khatib — Vice President Known as "The Analyzer" — Amira holds both an MBA and a journalism degree. Her career spans Whole Foods Market, a CPG startup, a marketing agency, and venture capital, specializing in data narratives and food industry insights. LinkedIn: https://www.linkedin.com/in/amirakhatib/ Lindsay Levin — Venture Partner Joined the firm in connection with the Fund III close (February 2024). Former CMO at RXBAR, bringing deep consumer brand-building expertise in the better-for-you food and beverage space. Decision Process and Founder Preferences Bluestein Ventures operates as a co-managing partnership (Andrew Bluestein and Ashley Hartman), with a venture partner (Lindsay Levin) and VP (Amira Khatib). The firm is active and hands-on, going well beyond capital to offer time, experience, and network support — particularly around achieving product-market fit, operational scaling, and investor introductions. Founder preferences: Visionary entrepreneurs who challenge the status quo in food and wellness Teams with strategic vision paired with operational execution capability Purpose-driven founders with domain expertise in food, nutrition, or food technology Companies with clear defensibility through proprietary IP, brand moat, or platform network effects Geographic Focus US-focused, headquartered in Chicago, Illinois. Portfolio companies are nationally distributed across the US, with occasional international investments (Aux Labs, Canada). Thought Leadership and Community Bluestein Ventures is deeply embedded in the Chicago food-tech ecosystem. The firm hosts an Annual Investor Summit (fourth edition: December 5, 2025) featuring founders and fund updates. Andrew Bluestein moderated a panel on the Future of the Microbiome at HLTH USA (October 2025). The firm publishes a regular "Future of Food" video series on YouTube. Ashley Hartman was recognized on Ingeborg's Healthcare Power Investor List in December 2025. The firm serves as judges and mentors at Kellogg, Booth, Good Food Business Accelerator, and 1871.